Six Massachusetts college students are facing charges after police say they assaulted an active-duty soldier after luring him on the dating app Tinder as part of a social media trend. (Patrick Sison/AP)
Valentine's Day is just around the corner and while couples are set to shower each other with gifts and quality time, a study by the Pew Research Center found that three in 10 Americans are single and nearly half of them are turning to dating apps to find companionship.
Tinder appears to be the top choice in the world of online dating with 46 percent of American singles reporting that they have used the service. About 10 percent of adults have used other services like Bumble or Match.
Yet, with online dating app usage ticking up, are these matches successful? At least half of people reported mostly positive experiences while 48 percent said they experienced negative behavior online. The study found that men were more likely to report positive experiences compared to women. Users identifying as gay, lesbian, and bisexual were also more likely to report positive experiences.
For many, using the apps isn't about finding committed partners. Just 42 percent of Americans reported seeking long-term relationships, with 51 percent saying they were open to a committed relationship or casual dating. Among men, that number was slightly higher at 56 percent compared to 44 percent of women.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Catching you up on the stories you need to know this morning, mass shooting victims testify on Capitol Hill, the White House outlines its plan to vaccinate kids younger than five years old, and we break down how to protect yourself from monkeypox.
